You may find more results for this query on our sister sites: GenomeWeb and 360Dx.
NEW YORK – Janssen said on Monday it is seeking approval from the European Medicines Agency for amivantamab as a treatment for metastatic non-small cell lung cancer patients with EGFR exon 20 insertion mutations.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?Register for Free.